New Jersey
Cancer clinical trials in New Jersey
409 cancer studies are recruiting participants at sites in 59 cities across New Jersey as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every New Jersey city with a recruiting study
By research area: Breast Cancer (127), Lung Cancer (119), Lymphoma (76), Prostate Cancer (42), Pancreatic Cancer (25), Melanoma (20).
Middletown (128), Basking Ridge (127), Montvale (125), Hackensack (101), New Brunswick (95), East Brunswick (48), Morristown (43), Camden (23), Summit (22), Long Branch (19), Newark (17), Voorhees Township (16), Livingston (15), Paramus (15), Sewell (15), Englewood (14), Somerville (14), Toms River (14), Jersey City (13), Cherry Hill (12), Elizabeth (11), Neptune City (11), Paterson (11), Lakewood (10), Belleville (9), Moorestown (9), Hamilton (8), Florham Park (7), Teaneck (7), Pennington (6), Pompton (6), Flemington (5), Hackettstown (5), Mullica Hill (5), Newton (5), Ridgewood (5), Manahawkin (4), Red Bank (4), Brick (3), East Hanover (3), Piscataway (3), Plainsboro (3), Princeton (3), Cape May Court House (2), Edison (2), Egg Harbor (2), Freehold (2), Holmdel (2), Vineland (2), Clifton (1), Millburn (1), North Bergen (1), Nutley (1), Old Bridge (1), Perth Amboy (1), Saddle Brook (1), Somerset (1), Totowa (1), Whippany (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in New Jersey
Basic details from each study's public record (the 12 most recently updated of 409). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- New Brunswick
- Registry record
- NCT06686394 · updated
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- LeonaBio
- Recruiting in
- New Brunswick
- Registry record
- NCT05696626 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Recruiting in
- Basking Ridge · Hackensack · Middletown · and 2 more U.S. locations
- Registry record
- NCT07488676 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in New Jersey on ClinicalTrials.gov.
Lung cancer: recently updated in New Jersey
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- University of Texas Southwestern Medical Center
- Recruiting in
- Neptune City
- Registry record
- NCT02468024 · updated
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Recruiting in
- East Brunswick
- Registry record
- NCT07277413 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in New Jersey on ClinicalTrials.gov.
Prostate cancer: recently updated in New Jersey
Radiation Therapy Approaches for People With Prostate Cancer
- Phase 2
- All ages
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Recruiting in
- Basking Ridge · Middletown · Montvale
- Registry record
- NCT07751159 · updated
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Phase 3
- Ages 18 and older
- Male participants
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Recruiting in
- Camden · New Brunswick · Somerville · and 2 more U.S. locations
- Registry record
- NCT04423211 · updated
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Morristown
- Registry record
- NCT06136624 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in New Jersey on ClinicalTrials.gov.
Melanoma: recently updated in New Jersey
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Phase 3
- Ages 75 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Recruiting in
- Hackensack · Hackettstown · Long Branch · and 7 more U.S. locations
- Registry record
- NCT07068074 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in New Jersey on ClinicalTrials.gov.
Lymphoma: recently updated in New Jersey
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Recruiting in
- Basking Ridge · Middletown
- Registry record
- NCT02974647 · updated
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Belleville
- Registry record
- NCT06717347 · updated
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Morristown · Paramus
- Registry record
- NCT06890884 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in New Jersey on ClinicalTrials.gov.
Ask about studies in New Jersey
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections